Archvest Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Archvest Wealth Advisors's LLY Position: Q2 2026 in Review
Archvest Wealth Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $79.7K and bringing the position to 1,466 shares worth $1.76M. The position accounts for 1.02% of the portfolio, ranked #20.
Archvest Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.43M in Q4 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Archvest Wealth Advisors held 1,466 shares of Eli Lilly worth $1.76M as of Q2 2026.
- Archvest Wealth Advisors bought 78 Eli Lilly shares in Q2 2026, an estimated $79.7K.
- Eli Lilly made up 1.02% of Archvest Wealth Advisors's portfolio in Q2 2026, its #20 holding.
- Archvest Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- Archvest Wealth Advisors's Eli Lilly position peaked at $2.43M in Q4 2025.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Archvest Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.